335 filings
Page 8 of 17
424B8
0dc4t3 v57vy7z7
1 Jun 22
Prospectus unintentially filed late
5:13pm
8-K
yyo7wd3v
17 May 22
Other Events
7:31am
8-K
78ebbe ck
12 May 22
Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results
4:39pm
DEFA14A
b46zvp19
5 May 22
Additional proxy soliciting materials
6:38pm
8-K
y7errv32z3dl70x0
5 May 22
Ensysce Biosciences Announces New Clinical Results from Trials PF614-102 and PF614-MPAR-101
12:00am
DEFA14A
pq6sps41a7lh
2 May 22
Additional proxy soliciting materials
9:27am
8-K
m3r2082vuipftd lb
31 Mar 22
Ensysce Biosciences Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
5:28pm
8-K
yqxlx
8 Feb 22
Ensysce Biosciences Appoints Industry Veteran Lee Rauch to Board of Directors
4:28pm
S-8
qnzfwyhj
28 Jan 22
Registration of securities for employees
9:24pm
8-K
widgyx ozyo2e
27 Jan 22
Ensysce Biosciences Announces Results of Special Meeting of Stockholders
8:24am
DEFA14A
jup03x5xq7xl ee
18 Jan 22
Additional proxy soliciting materials
6:25am
424B3
je2bzcr m835
18 Jan 22
Prospectus supplement
6:21am
424B3
5hvrs0e574z la1wjc
18 Jan 22
Prospectus supplement
6:19am
8-K
9esu5yr0 9j4og
18 Jan 22
Entry into a Material Definitive Agreement
12:00am
424B3
jlt 5xgmrjz4
27 Dec 21
Prospectus supplement
4:26pm
424B3
h2ex11438x9jthjqy
27 Dec 21
Prospectus supplement
4:24pm
DEFA14A
v1qwv309oqfwi 6j
27 Dec 21
Additional proxy soliciting materials
4:22pm